© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Identifying HPV Types: Preventing Over Treatment and Under Treatment
May 06, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Stark Regional Disparities in US Life Expectancy Trends Revealed in Comprehensive Birth Cohort Analysis
May 06, 2025
Life expectancy increased steadily in the US West and Northeast across the 20th century, but gains were just minimal in Southern states, according to the findings.
Pertussis: A Brief Backgrounder for Primary Care
May 06, 2025
Cases of whooping cough in the US more than doubled in 2024, and 2 infants have died from the infection. Here is background on the infection and vaccine.
One in 5 US Adults Chooses Against Handwashing, Some Citing it as "Unnecessary," National Survey Finds
May 05, 2025
While 20% of US adults choose not to wash their hands at appropriate times, nearly half admitted to forgetting to do it, according to a new national survey.
Fecal Microbiota Treatment via Colonoscopy Safe, Effective for Recurrent C. Diff, Study Suggests
May 05, 2025
DDW 2025. Colonoscopic delivery of fecal therapy prevented recurrent C. diff infection in 95% of participants for 8 weeks, with mild GI adverse events reported by
BD Onclarity Added to ASCCP Guidelines: What It Means
May 05, 2025
An interview with Jeff Andrews, MD, FRCSC, of BD Life Sciences.
Multitarget Stool DNA Testing Outperforms FIT/FOBT for Completed Follow-up Colonoscopy in CRC-Vulnerable Populations
May 05, 2025
DDW 2025. Follow-up colonoscopy after a positive stool-based test was superior among adults aged 45-49 and across diverse populations whose original test was mt-sDNA.
Marschall Runge, MD PhD, Shares Thoughts on the Trajectory of Measles in the US
May 05, 2025
Measles, declared eradicated in the US 25years ago, has infected 900 Americans and is responsible for 3 deaths of children younger than age 5. How did we get here?
PAD Risk Amplifiers and Screening Strategies: A Talk with Foluso Fakorede, MD
May 02, 2025
ACP 2025: Dr Fakorede outlines PAD risk amplifiers, polyvascular disease connections, and when to screen using ABI, TBI, or exercise testing in high-risk patients.
AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Trials of Uncontrolled Asthma
May 02, 2025
The KALOS and LOGOS registration trials in patients with uncontrolled asthma compared the triple fixed dose BGF with dual combination therapy.